Two Sigma Advisers
LEGN icon

Two Sigma Advisers’s Legend Biotech LEGN Stock Holding History

Two Sigma Advisers’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-689,600
Closed -$15M – 1173
2025
Q4 		$15M Sell
689,600
-34,100
-5% -$977K 0.03% 422
2025
Q3 		$23.6M Buy
723,700
+7,600
+1% +$281K 0.05% 287
2025
Q2 		$25.4M Buy
716,100
+212,000
+42% +$6.87M 0.05% 290
2025
Q1 		$17.1M Buy
504,100
+176,700
+54% +$6.34M 0.04% 368
2024
Q4 		$10.7M Buy
327,400
+294,800
+904% +$12.2M 0.02% 465
2024
Q3 		$1.59M Buy
+32,600
New +$1.74M ﹤0.01% 1192
2024
Q1 		– Sell
-14,400
Closed -$866K – 2558
2023
Q4 		$866K Sell
14,400
-86,100
-86% -$5.46M ﹤0.01% 1703
2023
Q3 		$6.75M Buy
+100,500
New +$6.98M 0.02% 603
2022
Q2 		– Sell
-35,600
Closed -$1.29M – 2784
2022
Q1 		$1.29M Buy
35,600
+30,200
+559% +$1.19M ﹤0.01% 1493
2021
Q4 		$252K Buy
+5,400
New +$274K ﹤0.01% 2200
2021
Q3 		– Sell
-8,400
Closed -$345K – 2576
2021
Q2 		$345K Buy
+8,400
New +$285K ﹤0.01% 2090

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers's LEGN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 689,600 shares — an estimated $15M sold.

Two Sigma Advisers first reported a position in LEGN in Q2 2021 and held it in 11 quarters. The position peaked at $25.4M in Q2 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Two Sigma Advisers reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 689,600 Legend Biotech shares in Q1 2026, an estimated $15M.
  • Two Sigma Advisers first reported a position in Legend Biotech in Q2 2021 and held it in 11 quarters.
  • Two Sigma Advisers's Legend Biotech position peaked at $25.4M in Q2 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.